retatrutide eua Peptide Therapy Retatrutide - Transforma Peptides

My twitter usage has gone down by about a third to about a half

An observational study published in 2023 in Diabetes Care that looked to determine whether the use of GLP-1 medications was associated with an increased risk of thyroid cancer found that in 1-3 years of treatment, the risk for thyroid cancer was increased for those taking GLP-1 medications (2)

WEIGHT-LOSS EXPERTS PREDICT 5 MAJOR TREATMENT CHANGES LIKELY TO EMERGE IN 2026 "Retatrutide is a more mild agonist of GLP-1," said Huberman

Medication for Obesity

In practice, it can leave you feeling like your tank is perpetually at one-quarter rather than cycling between full and empty

Whether anyone is actually taking the medication or not